Effects of vascular risk factors and APOE ε4 on white matter integrity and cognitive decline

Neurology

Volumn 84, Issue 11, 2015, Pages 1128-1135

  Wang, Rui ^a   Fratiglioni, Laura ^a,b   Laukka, Erika J ^a   Lövdén, Martin ^a   Kalpouzos, Grégoria ^a   Keller, Lina ^a   Graff, Caroline ^c   Salami, Alireza ^a   Bäckman, Lars ^a,b   Qiu, Chengxuan ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b STOCKHOLM GERONTOLOGY RESEARCH CENTER   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL EXAMINATION; COGNITION; COGNITIVE DEFECT; DIABETES MELLITUS; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; HYPERTENSION; INTERVIEW; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEAN DIFFUSIVITY; MINI MENTAL STATE EXAMINATION; NERVOUS SYSTEM PARAMETERS; PRIORITY JOURNAL; RISK FACTOR; SMOKING; WHITE MATTER; WHITE MATTER HYPERINTENSITY; COGNITION DISORDERS; GENETICS; HEALTH SURVEY; HETEROZYGOTE; MIDDLE AGED; PATHOLOGY; PROCEDURES; SWEDEN; TRENDS; VASCULAR DISEASES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; COGNITION DISORDERS; DIFFUSION TENSOR IMAGING; FEMALE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RISK FACTORS; SWEDEN; VASCULAR DISEASES; WHITE MATTER;

EID: 84925337089     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001379     Document Type: Article

References (34)

1. Kennedy KM, Raz N. Pattern of normal age-related regional differences in white matter microstructure is modified by vascular risk. Brain Res 2009;1297:41-56.
2. Burgmans S, van Boxtel MP, Gronenschild EH, et al. Multiple indicators of age-related differences in cerebral white matter and the modifying effects of hypertension. Neuroimage 2010;49:2083-2093.
3. Falvey CM, Rosano C, Simonsick EM, et al. Macro- and microstructural magnetic resonance imaging indices associated with diabetes among community-dwelling older adults. Diabetes Care 2013;36:677-682.
4. Qiu C, Sigurdsson S, Zhang Q, et al. Diabetes, markers of brain pathology and cognitive function: the Age, Gene/Environment Susceptibility-Reykjavik Study. Ann Neurol 2014;75:138-146.
5. Vernooij MW, Ikram MA, Vrooman HA, et al. White matter microstructural integrity and cognitive function in a general elderly population. Arch Gen Psychiatry 2009;66:545-553.
6. Charlton RA, Barrick TR, McIntyre DJ, et al. White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology 2006;66:217-222.
7. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 2002;51: 1256-1262.
8. Bangen KJ, Beiser A, Delano-Wood L, et al. APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline. J Stroke Cerebrovasc Dis 2013;22:1361-1369.
9. Rodrigue KM, Rieck JR, Kennedy KM, Devous MD Sr, Diaz-Arrastia R, Park DC. Risk factors for beta-amyloid deposition in healthy aging: vascular and genetic effects. JAMA Neurol 2013;70:600-606.
10. Rydwik E, Welmer AK, Kareholt I, Angleman S, Fratiglioni L, Wang HX. Adherence to physical exercise recommendations in people over 65: the SNAC-Kungsholmen Study. Eur J Public Health 2013;23:799-804.
11. Wang R, Fratiglioni L, Laveskog A, et al. Do cardiovascular risk factors explain the link between white matter hyperintensities and brain volumes in old age? A population-based study. Eur J Neurol 2014;21:1076-1082.
12. Lövdén M, Laukka EJ, Rieckmann A, et al. The dimensionality of between-person differences in white matter microstructure in old age. Hum Brain Mapp 2013;34: 1386-1398.
13. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487-1505.
14. Acosta-Cabronero J, Williams GB, Pengas G, Nestor PJ. Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. Brain 2010;133:529-539.
15. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
16. Goodall I. HbA1c standardisation destination: global IFCC standardisation. How, why, where and when: a tortuous pathway from kit manufacturers, via inter-laboratory lyophilized and whole blood comparisons to designated national comparison schemes. Clin Biochem Rev 2005;26:5-19.
17. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37(suppl 1): S81-S90.
18. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
19. Penke L, Munoz Maniega S, Murray C, et al. A general factor of brain white matter integrity predicts information processing speed in healthy older people. J Neurosci 2010; 30:7569-7574.
20. Tangney CC, Li H, Wang Y, et al. Relation of DASH and Mediterranean-like dietary patterns to cognitive decline in older persons. Neurology 2014;83:1410-1416.
21. Gons RA, van Norden AG, de Laat KF, et al. Cigarette smoking is associated with reduced microstructural integrity of cerebral white matter. Brain 2011;134:2116-2124.
22. Burzynska AZ, Preuschhof C, Bäckman L, et al. Agerelated differences in white matter microstructure: region-specific patterns of diffusivity. Neuroimage 2010; 49:2104-2112.
23. Kanchibhotla SC, Mather KA, Wen W, Schofield PR, Kwok JB, Sachdev PS. Genetics of ageing-related changes in brain white matter integrity: a review. Ageing Res Rev 2013;12:391-401.
24. Nyberg L, Salami A. The APOE ε4 allele in relation to brain white-matter microstructure in adulthood and aging. Scand J Psychol 2014;55:263-267.
25. Selnes P, Aarsland D, Bjornerud A, et al. Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment. J Alzheimers Dis 2013;33:723-736.
26. Vernooij MW, de Groot M, van der Lugt A, et al. White matter atrophy and lesion formation explain the loss of structural integrity of white matter in aging. Neuroimage 2008;43:470-477.
27. Smith EE, Schneider JA, Wardlaw JM, Greenberg SM. Cerebral microinfarcts: the invisible lesions. Lancet Neurol 2012;11:272-282.
28. Zhuang L, Sachdev PS, Trollor JN, et al. Microstructural white matter changes in cognitively normal individuals at risk of amnestic MCI. Neurology 2012;79:748-754.
29. Sachdev PS, Zhuang L, Braidy N, Wen W. Is Alzheimer's disease of the white matter? Curr Opin Psychiatry 2013; 26:244-251.
30. Maillard P, Seshadri S, Beiser A, et al. Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol 2012;11:1039-1047.
31. Yau PL, Hempel R, Tirsi A, Convit A. Cerebral white matter and retinal arterial health in hypertension and type 2 diabetes mellitus. Int J Hypertens 2013;2013:329602.
32. de Leeuw FE, Richard F, de Groot JC, et al. Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke 2004;35:1057-1060.
33. Ryan L, Walther K, Bendlin BB, Lue LF, Walker DG, Glisky EL. Age-related differences in white matter integrity and cognitive function are related to APOE status. Neuroimage 2011;54:1565-1577.
34. Pasternak O, Sochen N, Gur Y, Intrator N, Assaf Y. Free water elimination and mapping from diffusion MRI. Magn Reson Med 2009;62:717-730.